Compare Cytokinetics Inc (CYTK) vs SpaceX (SPCX) Price & Performance

Cytokinetics IncTrade

SpaceXTrade

Price performance (Past 24H)

Key statistics

Cytokinetics Inc vs SpaceX — how do they compare? Cytokinetics Inc trades at $62.58 (market cap $8.62B), while SpaceX trades at $161.86 (market cap $2.18T). The key difference: SpaceX is far larger — about 252.9× Cytokinetics Inc's market cap, and SpaceX is trading nearer its 52-week high, Cytokinetics Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Cytokinetics Inc for 19 Days and SpaceX for 41 Days on average.

	CYTK	SPCX
Market Cap	$8.62B	$2.18T
Volume	2,594,626	68,508,567
Sector	Health	Industrials
52-Week High	$87.26	$202.09
52-Week Low	$54.76	$108.27
Typical Hold Time	19 Days	41 Days
Enterprise Value	$8.72B	$2.12T

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cytokinetics Inc

Cytokinetics (CYTK) trades at $62.48, up 2.23% today, but faces bearish technical signals with 18 sell indicators versus 4 buy signals. The company shows strong revenue growth potential with recent positive Phase 3 trial results for aficamten in non-obstructive HCM, though it operates at significant losses with a -1,321% net income margin. Cash flow remains heavily dependent on financing activities, with operating cash flow negative at -$555 million in 2026.

Wall Street maintains strong bullish sentiment with 97% buy ratings and a $112.60 consensus price target, representing 80% upside potential. Key risks include continued cash burn, competitive pressure from Bristol Myers Squibb's Camzyos, and the need for successful commercialization of pipeline drugs. The stock's valuation appears stretched at 114x sales given current financial performance.

SpaceX

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

CYTK

100% Buy0% Sell

Avg holding period · 19 Days

SPCX

17% Buy83% Sell

Avg holding period · 41 Days

Top news

Latest headlines on both assets

CYTK

View details →

SPCX

AST SpaceMobile shares drop 6% as SpaceX secures low-band spectrum, tightening competition for satellite phone links.24/7 Wall Street · 4 hours agoBearish SpaceX's Starlink expands mobile service, pressuring AT&T, Verizon, and T-Mobile shares.Proactive Investors · 5 hours agoBearish SpaceX rises 4% after buying nationwide low-band spectrum, pressuring Verizon and AT&T stocks down 7%.24/7 Wall Street · 5 hours agoNeutral View details →

About Cytokinetics Inc

Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.

About SpaceX

SpaceX is the world's leading aerospace manufacturer and launch provider. It designs and operates reusable rockets, spacecraft, and Starlink, a global satellite internet service with over 10 million subscribers across 160 countries.